Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-24-109381
Filing Date
2024-10-17
Accepted
2024-10-17 08:11:18
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm2425989d1_424b5.htm 424B5 5200
2 GRAPHIC tm2425989d1_424b5img001.jpg GRAPHIC 6696
  Complete submission text file 0001104659-24-109381.txt   15607
Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5
Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621
XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-269429 | Film No.: 241375949
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)